DNER and cancer: Several studies have shown that BET bromodomain inhibitors are highly effective against various intractable cancers, including triple negative breast cancer8, pancreatic cancer9, and NMC22, although resistance to BET bromodomain inhibition can be acquired through various mechanisms8,23.